Humour, religion musulmane et laïcité au Québec : analyse du spectacle Nos droits et libertés (2017–2021) de l’humoriste Guy Nantel
International Journal of Canadian Studies · 01.09.2026 · 64 · 255-276
DOI: 10.3138/ijcs-2025-0029 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Canadian Studies, erschienen am 01.09.2026. Verfasst von Sophie-Anne Morency. Die Arbeit nennt 71 Literaturangaben.
Abstract (Originalsprache)
This article analyzes how Islam and Muslim individuals are depicted in humor, using the case of comedian Guy Nantel’s show Nos droits et libertés (2017–2021). This show ranked among the most attended paid performing arts shows in Quebec in 2018. To do so, we first examine the comedian’s personal context and the sociopolitical context in which the show takes place, both of which are essential for understanding humor. We then conduct a critical discourse analysis based on a thematically selected sample from Nos droits et libertés. Our analysis reveals that certain strategies used by U.S. comedians to avoid criticism for spreading racist humor are also employed by Guy Nantel and that many of his humorous discourses on Islam and Muslim individuals rely on themes characteristic of cultural racism.
Zitieren
APA
Morency, S. (2026). Humour, religion musulmane et laïcité au Québec : analyse du spectacle Nos droits et libertés (2017–2021) de l’humoriste Guy Nantel. International Journal of Canadian Studies, 64, 255-276. https://doi.org/10.3138/ijcs-2025-0029
Vancouver
Morency S. Humour, religion musulmane et laïcité au Québec : analyse du spectacle Nos droits et libertés (2017–2021) de l’humoriste Guy Nantel. International Journal of Canadian Studies. 2026;64:255-276. doi:10.3138/ijcs-2025-0029
BibTeX
@article{Morency2026,
author = {Morency, Sophie-Anne},
title = {Humour, religion musulmane et laïcité au Québec : analyse du spectacle Nos droits et libertés (2017–2021) de l’humoriste Guy Nantel},
journal = {International Journal of Canadian Studies},
year = {2026},
volume = {64},
pages = {255--276},
doi = {10.3138/ijcs-2025-0029}
}
EUVIMED